• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Emerging Lessons From COVID-19 for the US Clinical Research Enterprise.

作者信息

Angus Derek C, Gordon Anthony C, Bauchner Howard

机构信息

UPMC and the University of Pittsburgh Schools of the Health Sciences, Pittsburgh, Pennsylvania.

Senior Editor, JAMA.

出版信息

JAMA. 2021 Mar 23;325(12):1159-1161. doi: 10.1001/jama.2021.3284.

DOI:10.1001/jama.2021.3284
PMID:33635309
Abstract
摘要

相似文献

1
Emerging Lessons From COVID-19 for the US Clinical Research Enterprise.COVID-19给美国临床研究事业带来的新教训。
JAMA. 2021 Mar 23;325(12):1159-1161. doi: 10.1001/jama.2021.3284.
2
International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary.新型冠状病毒肺炎康复者血浆采集与使用国际论坛：方案、挑战与经验教训：总结
Vox Sang. 2021 Nov;116(10):1117-1135. doi: 10.1111/vox.13113. Epub 2021 May 20.
3
Response Letter: Treatment for emerging viruses: Convalescent plasma and COVID-19.回复信：新兴病毒的治疗：康复血浆与新型冠状病毒肺炎
Transfus Apher Sci. 2021 Feb;60(1):102929. doi: 10.1016/j.transci.2020.102929. Epub 2020 Sep 1.
4
Covid-19 convalescent plasma and SARS-CoV-2 viral variants.新冠康复者血浆与严重急性呼吸综合征冠状病毒2病毒变体
Transfus Clin Biol. 2021 Aug;28(3):306. doi: 10.1016/j.tracli.2021.05.008. Epub 2021 May 29.
5
Convalescent plasma for COVID-19 considerations.关于新冠病毒病恢复期血浆的考量
Transfus Apher Sci. 2021 Feb;60(1):102927. doi: 10.1016/j.transci.2020.102927. Epub 2020 Aug 27.
6
Use of Convalescent Plasma in the Management of COVID-19.康复期血浆在新型冠状病毒肺炎治疗中的应用
Mo Med. 2021 Mar-Apr;118(2):118.
7
Convalescent plasma therapy in patients with COVID-19.新型冠状病毒肺炎患者的恢复期血浆治疗
Transfus Apher Sci. 2021 Feb;60(1):103017. doi: 10.1016/j.transci.2020.103017. Epub 2020 Nov 19.
8
[COVID-19: blood sufficiency versus convalescent plasma?].[新冠病毒肺炎：血液充足疗法与康复期血浆疗法？]
Rev Med Chil. 2020 Jun;148(6):721-723. doi: 10.4067/S0034-98872020000600721.
9
Convalescent plasma (CP) therapy in patients with COVID-19.新冠病毒病患者的恢复期血浆疗法
Transfus Apher Sci. 2021 Feb;60(1):103018. doi: 10.1016/j.transci.2020.103018. Epub 2020 Nov 19.
10
Appropriate selection of convalescent plasma donors for COVID-19.为新冠病毒病（COVID-19）康复者血浆捐献者进行恰当选择。
Lancet Infect Dis. 2021 Feb;21(2):168-169. doi: 10.1016/S1473-3099(20)30470-9. Epub 2020 Jun 15.

引用本文的文献

1
Optimising cardiac surgery outcomes in people with diabetes: the OCTOPuS pilot feasibility study.优化糖尿病患者心脏手术的预后：OCTOPuS试点可行性研究
Health Technol Assess. 2025 Aug;29(39):1-31. doi: 10.3310/POYW3311.
2
Health research versus the virus: strengthening systems, saving lives.卫生研究对抗病毒：加强体系，拯救生命。
Health Res Policy Syst. 2025 Jul 25;23(1):95. doi: 10.1186/s12961-025-01354-4.
3
Hurdles for the Delivery of Multinational Randomized Clinical Trials.开展跨国随机临床试验的障碍。
JAMA Netw Open. 2025 Jul 1;8(7):e2518503. doi: 10.1001/jamanetworkopen.2025.18503.
4
How to build a better clinical trial ecosystem for future infectious disease emergencies in Japan: Findings from a narrative review and stakeholder meetings.如何为日本未来的传染病紧急情况构建更好的临床试验生态系统：一项叙述性综述及利益相关者会议的结果
Glob Health Med. 2025 Apr 30;7(2):96-105. doi: 10.35772/ghm.2024.01082.
5
Barriers and facilitators to conducting human subjects research at a safety net institution from the perspective of researchers.从研究人员的角度看，在安全网机构开展人体受试者研究的障碍与促进因素。
PLoS One. 2025 Jan 8;20(1):e0313530. doi: 10.1371/journal.pone.0313530. eCollection 2025.
6
Embedding clinical trial elements into clinical practice: Experiences from trial designers and implementers.将临床试验要素融入临床实践：来自试验设计者和实施者的经验。
J Clin Transl Sci. 2024 Oct 17;8(1):202. doi: 10.1017/cts.2024.647. eCollection 2024.
7
Overcoming the barriers to better evidence generation from clinical trials.克服临床试验中产生更好证据的障碍。
Trials. 2024 Sep 16;25(1):614. doi: 10.1186/s13063-024-08460-8.
8
The response of Canada's clinical health research ecosystem to the COVID-19 pandemic.加拿大临床卫生研究生态系统对 COVID-19 大流行的反应。
CMAJ. 2024 Jun 16;196(23):E779-E788. doi: 10.1503/cmaj.230760.
9
The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided.临床试验与医学实践的整合：弥合分歧。
JAMA. 2024 Jul 9;332(2):153-162. doi: 10.1001/jama.2024.4088.
10
The times are changing: A primer on novel clinical trial designs and endpoints in critical care research.时代在变：重症监护研究中新型临床试验设计与终点的入门指南。
Am J Health Syst Pharm. 2024 Sep 9;81(18):890-902. doi: 10.1093/ajhp/zxae134.